Font Size: a A A

The 3DCRT Surival Benefit Evaluation Of Hepatocellular Carcinoma Patients

Posted on:2018-01-01Degree:DoctorType:Dissertation
Country:ChinaCandidate:F SuFull Text:PDF
GTID:1314330518952299Subject:Oncology
Abstract/Summary:PDF Full Text Request
Part 1The efficacy of three-dimensional conformal radiotherapy(3D-CRT)compared to hepatic resection(HR)for small hepatocellular carcinoma(HCC).Objective: The aim of this study is to evaluate the efficacy of 3D-CRT in small hepatocellular carcinoma.Methods: Between January 2000 and December 2014,201 patients diagnosed with small HCC were included in this study.The study groups were47 HCC patients treated with 3D-CRT(RT group)and 154 controls treated with hepatic resection(HR group).To reduce confounding bias between the groups,propensity score matching(PSM)was conducted.Kaplan-Meier and Cox regression analysis were used to compare overall survival(OS)and progression-free survival(PFS)rates.Subgroup analysis based on tumor size and the hepatic sclerosis was also carried out.Results: The 1-,3-,5-year PFS rates of the RT group were 87%?49%?36%,and those of the HR group were 84%?63%?58%,repectively,p=0.041.The 1-,3-,5-year OS rates of the RT group were 92%,62% and51%,and those of the HR group were 92%,80% and 58%,repectively,p=0.020.However,After PSM,the OS rates of the two groups were similar,and for the patients with smaller tumors and those who uncomplicated hepatic cirrhosis(all p>0.05).Multivariate analyses revealed that Child-Pugh class B,AFP?400ng/mL and complicated hepatic cirrhosis are independent predictors of poor prognosis in small HCC patients.Conclusion: 3D-CRT and HR are similar in the treatment of small HCC.3D-CRT can be used as the first choice of treatment.Part 2A comparison of chemoembolization combination with and without radiotherapy for unresectable HCCBackground and Objective: This study evaluated the efficacy and safety of TACE combined with 3D-CRT on the objective response rates and survival of patients with unresectable HCC.Methods: Between January 2000 and December 2014,we retrospectively studied 181 patients with unresectable HCC in this study.The study groups were103 HCC patients treated with TACE combined with 3D-CRT(RT group)and78 controls treated with TACE alone(non-RT group).To reduce confounding bias between the groups,PSM was also conducted.Tumor response rate was analyzed and compared between the two groups.Kaplan-Meier and Cox regression analysis were used to compare OS and failure patterns.Result: The objective response rate of tumor was higher in the RT group(70% vs 31%,p< 0.001).The 1-,3-,5-year OS rates of the RT group were 80%,30% and 17%,and those of the non-RT group were 53%,18% and12%,repectively,p=0.006.RT group provided a better survival over non-RT group.Propensity scoring analyses also showed that RT group was associated with better objective responses and survival than non-RT group.Cox multivariate analyses revealed that multiple nodules,Child-Pugh class B,AFP?400ng/mL are independent predictors of poor prognosis in patients with unresectable HCC.Intrahepatic failure was similar in the RT and non-RT groups.Side effects from radiotherapy were rarely severe.Conclusion: TACE combined with 3D-CRT can significantly improve long-term survival compared with TACE alone.The outcome of unresectable HCC can be influenced by 3D-CRT.Part 3The efficacy of 3D-CRT compared to HR for in advanced HCC with portal vein tumor thrombosis(PVTT).Objective: The purpose of this study is to evaluate the safety and efficacy of 3D-CRT for advanced HCC with PVTT.Methods: We retrospectively studied 323 advanced HCC patients with PVTT between January 2000 and December 2014.The study groups were 134 HCC patients treated with 3D-CRT(RT group)and 189 controls treated with HR(HR group).In order to reduce confounding bias between the groups,PSM was conducted.Kaplan-Meier and Cox regression analysis were used to compare OS.Moreover,subgroup analysis based on portal vein tumor thrombosis type and combination of TACE was carried out.Results: The 1-,3-,5-year OS rates of the RT group were 54%?18%and 8%,and those of the HR group were 62%?43 % and 32%,repectively,p=0.003.However,the OS rates of the two groups were similar after PSM(p=0.058).In the subgroup of PVTT type analyze,The 1-,2-,3-year OS of patients treated with RT was significantly worse than those treated with HR in type ? PVTT(p<0.001).However,the OS rates of the two groups were similar in type ? PVTT(p=0.612).Moreover,the OS rates of patients treated with RT was significantly better than those treated with HR in type ? PVTT(p=0.041).Multivariate analyses revealed that tumor size ?10 cm,Child-Pugh class B and type ? PVTT are independent predictors of poor prognosis in HCC patients with PVTT.Conclusion: 3DCRT and HR are similar in the treatment of advanced HCC with PVTT.3DCRT can be used as the first choice of in type ?/? PVTT of HCC.
Keywords/Search Tags:hepatocellular carcinoma, three-dimensional conformal radiotherapy, transcatheter arterial chemoembolization, portal vein tumor thrombosis, hepatic resection, progression-free survival, overall survival rate, prognosis factor
PDF Full Text Request
Related items
Survival Prognosis Of Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombus After Adjuvant Hepatic Transcatheter Arterial Chemoembolization Combined With Portal Vein Chemotherapy
The Survival Analysis Of Transarterial Chemoembolization Plus Three Dimensional Radiotherapy For Hepatocellular Carcinoma Combined With Portal Vein Tumor Thrombosis
Curative Effect And Prognostic Risk Factor Of Surgical Resection Combined With TACE In The Treatment Of Advanced Hepatocellular Carcinoma
Comparison Of The Prognosis Of Hepatic Resection And Transcatheter Arterial Chemoembolization For Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Adjuvant Transcatheter Arterial Chemoembolization After Radical Resection Of Hepatocellular Carcinoma Patients With Tumor Size Less Than 5cm
Therapeutic Effect Of Transcatheter Arterial Chemoembolization Combined With Portal Vein 125I Particle Implantation And Stent Implantation In Treatment Of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
TACE Combine With 3D-CRT Treat For HCC With PVTT And Multiple Factors Analysis Of Survival Prognosis
The Clinical Application Of CT Guided1251Seeds And Fluorouracil Implants Combined With Transcatheter Arterial Chemoembolization For Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombosis
Comparison Of Surgical Resection Versus Transarterial Chemoembolization In Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombosis
10 The Value Of IVIM And DCE-MR In Patients With Hepatocellular Carcinoma Treat With Transcatheter Arterial Chemoembolization